# A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486

> **NCT03745625** · PHASE1 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 16 (actual)

## Conditions studied

- Anesthesia
- Sedation

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03745625
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-09
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-08-27
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03745625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03745625, "A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03745625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*